• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美托洛尔反应性葡萄膜炎

Metoprolol responding uveitis.

作者信息

Kassif Y, Rehany U, Rumelt S

机构信息

1Department of Ophthalmology, Western Galilee, Nahariya Medical Center, Nahariya, Israel.

出版信息

Eye (Lond). 2004 Jan;18(1):41-3. doi: 10.1038/sj.eye.6700507.

DOI:10.1038/sj.eye.6700507
PMID:14707964
Abstract

BACKGROUND

Noninfectious uveitis is usually managed by topical and systemic corticosteroids and in refractory cases by immunosuppressive drugs.

OBJECTIVE

To describe a patient with noninfectious anterior and posterior uveitis, refractory to corticosteroids, and immunosuppressive therapy, which responded to systemic metoprolol.

PATIENT AND METHODS

A 49-year-old patient was treated for 3 years with topical and systemic corticosteroids and systemic cyclosporin A for a bilateral anterior and posterior uveitis of unknown origin. The treatment did not result in resolution of the uveitis. A bilateral uveitic glaucoma developed and necessitated neodymium : YAG laser iridotomies and antiglaucoma medications. A systemic beta-blocker, metoprolol tartrate 50 mg b.i.d., was administered for palpitations because of idiopatic paroxysmal supraventricular tachycardia and short ventricular tachycardia.

RESULTS

Following administration of metoprolol tartrate, the bilateral uveitis resolved. The corticosteroids and the cyclosporin A were withdrawn after 6 weeks without any recurrence. A trial to discontinue metoprolol after 6 months resulted in flare-up of the disease and only following its readministration the inflammation resolved. The patient is currently under metoprolol for a year without flare-ups.

CONCLUSIONS

The use of metoprolol tartrate in this patient resulted in resolution of bilateral noninfectious uveitis. This is the first report of non-antiinfectious, antiinflammatory, or immunosuppressive drug effective for uveitis. It is possible that a subgroup of resistant uveitis may respond to drugs other than the traditional drugs, such as metoprolol, and that other forms of uveitis of unidentified origin exist.

摘要

背景

非感染性葡萄膜炎通常采用局部和全身使用皮质类固醇治疗,难治性病例则使用免疫抑制药物。

目的

描述一名患有非感染性前、后葡萄膜炎的患者,该患者对皮质类固醇和免疫抑制治疗无效,但对全身使用美托洛尔有反应。

患者与方法

一名49岁患者因不明原因的双侧前、后葡萄膜炎接受局部和全身皮质类固醇以及全身环孢素A治疗3年。治疗未能使葡萄膜炎消退。双侧葡萄膜炎性青光眼发展,需要进行钕:YAG激光虹膜切开术和抗青光眼药物治疗。因特发性阵发性室上性心动过速和短阵室性心动过速导致心悸,给予全身β受体阻滞剂酒石酸美托洛尔50毫克,每日两次。

结果

服用酒石酸美托洛尔后,双侧葡萄膜炎消退。6周后停用皮质类固醇和环孢素A,无任何复发。6个月后尝试停用美托洛尔导致疾病复发,仅在重新给药后炎症才消退。该患者目前服用美托洛尔一年,无疾病复发。

结论

该患者使用酒石酸美托洛尔使双侧非感染性葡萄膜炎消退。这是关于对葡萄膜炎有效的非抗感染、抗炎或免疫抑制药物的首例报告。可能存在一部分耐药性葡萄膜炎患者对美托洛尔等传统药物以外的药物有反应,并且存在其他不明原因的葡萄膜炎形式。

相似文献

1
Metoprolol responding uveitis.美托洛尔反应性葡萄膜炎
Eye (Lond). 2004 Jan;18(1):41-3. doi: 10.1038/sj.eye.6700507.
2
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.用于非感染性后葡萄膜炎的醋酸氟轻松植入剂(Retisert):一项多中心随机临床研究的34周结果
Ophthalmology. 2006 Jun;113(6):1020-7. doi: 10.1016/j.ophtha.2006.02.021. Epub 2006 May 9.
3
Metoprolol responding uveitis.美托洛尔反应性葡萄膜炎
Eye (Lond). 2005 Jun;19(6):719-20; author reply 720. doi: 10.1038/sj.eye.6701616.
4
Rituximab as a treatment option for refractory endogenous anterior uveitis.
Ophthalmic Res. 2007;39(3):184-6. doi: 10.1159/000103239. Epub 2007 May 25.
5
Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.皮下注射达克珠单抗治疗非感染性葡萄膜炎的初步评估:一项多中心非对照干预性病例系列研究
Ophthalmology. 2005 May;112(5):764-70. doi: 10.1016/j.ophtha.2004.12.034.
6
Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.醋酸氟轻松植入剂治疗后葡萄膜炎的一项试点试验的长期随访结果
Ophthalmology. 2005 Jul;112(7):1192-8. doi: 10.1016/j.ophtha.2005.03.013.
7
Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).使用抗TNFα(英夫利昔单抗)对难治性后葡萄膜炎进行长期治疗。
Eye (Lond). 2005 Aug;19(8):841-5. doi: 10.1038/sj.eye.6701689.
8
Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study.白内障手术中玻璃体内注射曲安奈德在葡萄膜炎性眼病中的应用:初步研究
J Cataract Refract Surg. 2007 Jul;33(7):1278-83. doi: 10.1016/j.jcrs.2007.03.030.
9
Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.英夫利昔单抗治疗难治性后葡萄膜炎:一项7年随访研究。
Scand J Rheumatol. 2009 Jan-Feb;38(1):58-62. doi: 10.1080/03009740802366076.
10
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.英夫利昔单抗治疗白塞病难治性后葡萄膜炎的长期疗效:一项24个月的随访研究。
Rheumatology (Oxford). 2007 Jul;46(7):1161-4. doi: 10.1093/rheumatology/kem101. Epub 2007 May 3.